NASDAQ:ABUS   Arbutus Biopharma Corporation
Channel play, reversal confirmed, looking for 10%+. Could launch if it breaks out.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.